Literature DB >> 15735215

Inflammatory markers and diabetic retinopathy in type 1 diabetes.

Kenneth E Izuora1, H Peter Chase, William E Jackson, Joseph R Coll, Iris M Osberg, Peter A Gottlieb, Marian J Rewers, Satish K Garg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15735215     DOI： 10.2337/diacare.28.3.714

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  14 in total

1.  Association between red blood cell distribution width and macrovascular and microvascular complications in diabetes.

Authors:  N Malandrino; W C Wu; T H Taveira; H B Whitlatch; R J Smith
Journal:  Diabetologia       Date:  2011-10-15       Impact factor: 10.122

2.  Impact of periodontal disease on outcomes in diabetes.

Authors:  Kenneth Izuora; Echezona Ezeanolue; Karen Schlauch; Michael Neubauer; Civon Gewelber; Guillermo Umpierrez
Journal:  Contemp Clin Trials       Date:  2015-01-24       Impact factor: 2.226

3.  Changes in Inflammatory and Bone Turnover Markers After Periodontal Disease Treatment in Patients With Diabetes.

Authors:  Kenneth E Izuora; Echezona E Ezeanolue; Michael F Neubauer; Civon L Gewelber; Gayle L Allenback; Guogen Shan; Guillermo E Umpierrez
Journal:  Am J Med Sci       Date:  2016-04-23       Impact factor: 2.378

4.  Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy.

Authors:  Mariusz Nowak; Tomasz Wielkoszyński; Bogdan Marek; Beata Kos-Kudła; Elzbieta Swietochowska; Lucyna Siemińska; Jacek Karpe; Dariusz Kajdaniuk; Joanna Głogowska-Szelag; Katarzyna Nowak
Journal:  Clin Exp Med       Date:  2009-12-11       Impact factor: 3.984

5.  Neural inflammation and the microglial response in diabetic retinopathy.

Authors:  Steven F Abcouwer
Journal:  J Ocul Biol Dis Infor       Date:  2012-04-24

6.  cAMP activates the generation of reactive oxygen species and inhibits the secretion of IL-6 in peripheral blood mononuclear cells from type 2 diabetic patients.

Authors:  Camila Armond Isoni; Erica Abreu Borges; Clara Araújo Veloso; Rafael Teixeira Mattos; Miriam Martins Chaves; José Augusto Nogueira-Machado
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

7.  Epigallocatechin-3-gallate attenuates lipopolysaccharide-induced inflammation in human retinal endothelial cells.

Authors:  Hui-Yan Zhang; Jian-Yong Wang; Hang-Ping Yao
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

8.  C-reactive protein and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus.

Authors:  Xiu-Fen Yang; Yu Deng; Hong Gu; Apiradee Lim; Torkel Snellingen; Xi-Pu Liu; Ning-Li Wang; Amitha Domalpally; Ronald Danis; Ning-Pu Liu
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

9.  Cytokine Levels in Human Vitreous in Proliferative Diabetic Retinopathy.

Authors:  Dean F Loporchio; Emily K Tam; Jane Cho; Jaeyoon Chung; Gyungah R Jun; Weiming Xia; Marissa G Fiorello; Nicole H Siegel; Steven Ness; Thor D Stein; Manju L Subramanian
Journal:  Cells       Date:  2021-04-30       Impact factor: 6.600

10.  Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis.

Authors:  Thanh T Nguyen; Ekaterina Alibrahim; F M Amirul Islam; Ronald Klein; Barbara E K Klein; Mary Frances Cotch; Steven Shea; Tien Y Wong
Journal:  Diabetes Care       Date:  2009-06-23       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.